{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": -0.142116, "regularMarketPrice": 21.08, "exchange": "NGM", "shortName": "Aerovate Therapeutics, Inc.", "longName": "Aerovate Therapeutics, Inc.", "messageBoardId": "finmb_650355034", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1625059800000, "priceHint": 2, "earningsTimestampEnd": 1692359400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.13, "epsForward": -2.22, "epsCurrentYear": -2.42, "priceEpsCurrentYear": -8.710744, "sharesOutstanding": 24850800, "bookValue": 5.127, "fiftyDayAverage": 20.4152, "fiftyDayAverageChange": 0.66480064, "fiftyDayAverageChangePercent": 0.032564003, "twoHundredDayAverage": 21.3033, "twoHundredDayAverageChange": -0.22330093, "twoHundredDayAverageChangePercent": -0.010481987, "marketCap": 524601088, "forwardPE": -9.495496, "priceToBook": 4.1115665, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-30", "averageAnalystRating": "1.3 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.030000687, "regularMarketTime": 1684180805, "regularMarketDayHigh": 22.58, "regularMarketDayRange": "20.64 - 22.58", "regularMarketDayLow": 20.64, "regularMarketVolume": 22197, "regularMarketPreviousClose": 21.11, "bid": 0.0, "ask": 0.0, "bidSize": 8, "askSize": 13, "fullExchangeName": "NasdaqGM", "financialCurrency": "USD", "regularMarketOpen": 20.91, "averageDailyVolume3Month": 73348, "averageDailyVolume10Day": 60500, "fiftyTwoWeekLowChange": 9.95, "fiftyTwoWeekLowChangePercent": 0.8939802, "fiftyTwoWeekRange": "11.13 - 30.79", "fiftyTwoWeekHighChange": -9.710001, "fiftyTwoWeekHighChangePercent": -0.31536216, "fiftyTwoWeekLow": 11.13, "fiftyTwoWeekHigh": 30.79, "earningsTimestamp": 1684181100, "earningsTimestampStart": 1692013800, "displayName": "Aerovate Therapeutics", "symbol": "AVTE"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "930 Winter Street", "address2": "Suite M-500", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "617 443 2400", "website": "https://aerovatetx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Timothy P. Noyes M.B.A.", "age": 60, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 703800, "fmt": "703.8k", "longFmt": "703,800"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 10294180, "fmt": "10.29M", "longFmt": "10,294,180"}}, {"maxAge": 1, "name": "Mr. George A. Eldridge", "age": 59, "title": "CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 533894, "fmt": "533.89k", "longFmt": "533,894"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1269713, "fmt": "1.27M", "longFmt": "1,269,713"}}, {"maxAge": 1, "name": "Dr. Marinus  Verwijs Ph.D.", "age": 46, "title": "Sr. VP of CMC", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 439875, "fmt": "439.88k", "longFmt": "439,875"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Benjamin T. Dake Ph.D.", "age": 46, "title": "Founder, Pres, COO & Sec.", "yearBorn": 1976, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ralph W. Niven M.B.A., M.R, Ph.D., Pharm.S", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hunter  Gillies M.D.", "age": 56, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Timothy J. Pigot", "age": 51, "title": "Sr. VP of Commercial", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Donna  Dea", "title": "Head of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Susan  Fischer", "title": "Sr. VP of Devel. Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen K. Yu", "title": "Sr. VP of Quality", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}